Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 584 shares at $187.95 ($110K) on 2025-10-21, disclosed to the SEC on 2025-10-22.
Scheduled sale ($110k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $187.95 | 292 | $55K | 50.0% |
| 2 | $187.95 | 292 | $55K | 50.0% |
| Total | $187.95 avg | 584 | $110K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |